United Therapeutics (UTHR) Misses Q4 EPS by 49c
Tweet
Share
E-mail
Get Alerts UTHR Hot Sheet
Price: $547.25 --0%
Revenue Growth %: +1.5%
Financial Fact:
Operating income: 238.6M
Today's EPS Names:
EPAC, SAR, KRUS, More
Revenue Growth %: +1.5%
Financial Fact:
Operating income: 238.6M
Today's EPS Names:
EPAC, SAR, KRUS, More
Join SI Premium – FREE
United Therapeutics (NASDAQ: UTHR) reported Q4 EPS of $6.19, $0.49 worse than the analyst estimate of $6.68. Revenue for the quarter came in at $735.9 million versus the consensus estimate of $739.92 million.
For earnings history and earnings-related data on United Therapeutics (UTHR) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- China's DeepSeek developing its own AI chip - Reuters
- Wrap Technologies launches WrapShield platform with Israeli sensing firm deal
- Deutsche Bank Starts VNET Group Inc (VNET) at Buy
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
